http://healthcarefirms.com The Healthcare Industry Website Directory - Coming Soon Sat, 05 Feb 2011 02:14:44 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 http://healthcarefirms.com/seracare-life-sciences-inc/ http://healthcarefirms.com/seracare-life-sciences-inc/#comments Wed, 03 Mar 2010 00:29:30 +0000 admin SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, validation and production of human diagnostics and therapeutics. SeraCare’s innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking and contract research services. SeraCare’s quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly regulated life sciences industry.

]]> http://healthcarefirms.com/seracare-life-sciences-inc/feed/ 0 http://healthcarefirms.com/qiagen-nv/ http://healthcarefirms.com/qiagen-nv/#comments Sun, 21 Feb 2010 18:37:26 +0000 admin QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated bio-molecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control.

]]> http://healthcarefirms.com/qiagen-nv/feed/ 0 http://healthcarefirms.com/life-technologies-corporation/ http://healthcarefirms.com/life-technologies-corporation/#comments Sun, 21 Feb 2010 13:59:34 +0000 admin Life Technologies Corporation is a global biotechnology tools company dedicated to improving the human condition. Its systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of approximately $3.3 billion in 2009, employs approximately 9,000 people, has a presence in more than 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc.

]]> http://healthcarefirms.com/life-technologies-corporation/feed/ 0 http://healthcarefirms.com/biomoda-inc/ http://healthcarefirms.com/biomoda-inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Biomoda is a cancer diagnostics company focused on the development of accurate, inexpensive and noninvasive tests for the early detection of cancer. Current research and development operations, laboratory functions for both microscopy and assay formulation, and administrative offices are located in Albuquerque, NM.

]]> http://healthcarefirms.com/biomoda-inc/feed/ 0 http://healthcarefirms.com/burzynski-research-institute/ http://healthcarefirms.com/burzynski-research-institute/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Burzynski Research Institute, Inc. is a biopharmaceutical company committed to developing treatment for cancer based on genomic and epigenomic principles. Burzynski Research Institute (BRI) is based in Houston and Stafford, Texas, U.S.A., and is engaged in research and development of targeted gene therapies (antineoplastons or ANP) for the treatment of cancer. BRI was incorporated under the laws of the State of Delaware in 1984 in order to engage in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibitig peptides, amino acid derivatives and organic acids which are known under the trade name antineoplastons.

]]> http://healthcarefirms.com/burzynski-research-institute/feed/ 0 http://healthcarefirms.com/Chembio-Diagnostics-Inc/ http://healthcarefirms.com/Chembio-Diagnostics-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio’s two FDA approved rapid HIV tests are marketed in the U.S. by Inverness Medical Innovations, Inc. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through partnerships and distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP) technology, which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio’s pipeline of products incorporating this technology includes rapid tests for the screening of HIV and hepatitis C (HCV) using oral fluid samples as well as a multiplex screen and confirm rapid point-of-care diagnostic test for syphilis. Headquartered in Medford, NY, with approximately 100 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U.S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485.

]]> http://healthcarefirms.com/Chembio-Diagnostics-Inc/feed/ 0 http://healthcarefirms.com/CNS-Response-Inc/ http://healthcarefirms.com/CNS-Response-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin CNS Response has developed the first proven quantitative approach to guiding the treatment of patients with behavioral disorders. Using data from a digital electroencephalogram (EEG), which is a simple noninvasive procedure to measure brain function or physiology, CNS Response analyzes and then compares the output to a database of over 13,000 medication trials. This Referenced-EEG (rEEG

]]> http://healthcarefirms.com/CNS-Response-Inc/feed/ 0 http://healthcarefirms.com/Corgenix-Medical-Corp/ http://healthcarefirms.com/Corgenix-Medical-Corp/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders, including the world

]]> http://healthcarefirms.com/Corgenix-Medical-Corp/feed/ 0 http://healthcarefirms.com/Hemagen-Diagnostics-Inc/ http://healthcarefirms.com/Hemagen-Diagnostics-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Hemagen Diagnostics, Inc. is a biotechnology company that develops, manufactures, and markets approximately 68 Food and Drug Administration (

]]> http://healthcarefirms.com/Hemagen-Diagnostics-Inc/feed/ 0 http://healthcarefirms.com/IDEXX-Laboratories-Inc/ http://healthcarefirms.com/IDEXX-Laboratories-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for the production animal industry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 4,800 people and offers products to customers in over 100 countries.

]]> http://healthcarefirms.com/IDEXX-Laboratories-Inc/feed/ 0 http://healthcarefirms.com/Immucor-Inc/ http://healthcarefirms.com/Immucor-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Immucor, Inc. is a global in vitro diagnostics company specializing in the area of pre-transfusion diagnostics. It develops, manufacturers, and sells products used by hospital blood banks, clinical laboratories, and blood donor centers to detect and identify certain properties of human blood prior to patient transfusion. Immucor has revolutionized the industry through its dedication to automating manual processes in the blood bank laboratory.

]]> http://healthcarefirms.com/Immucor-Inc/feed/ 0 http://healthcarefirms.com/Interleukin-Genetics-Inc/ http://healthcarefirms.com/Interleukin-Genetics-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Interleukin Genetics, Inc. (NYSE Amex: ILI) develops and markets genetic tests that empower consumers to prevent certain chronic diseases and that assist pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics markets a line of genetic tests under the Inherent Health brand including Bone Health, Weight Management, Heart Health and Nutritional Needs.

]]> http://healthcarefirms.com/Interleukin-Genetics-Inc/feed/ 0 http://healthcarefirms.com/Meridian-Bioscience-Inc/ http://healthcarefirms.com/Meridian-Bioscience-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, urinary and respiratory infections. Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company’s products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals along with proteins and other biologicals used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices and diagnostics manufacturers in more than 60 countries around the world.

]]> http://healthcarefirms.com/Meridian-Bioscience-Inc/feed/ 0 http://healthcarefirms.com/Myriad-Genetics-Inc/ http://healthcarefirms.com/Myriad-Genetics-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Myriad Geneticsis a molecular diagnostic company at the forefront of the most exciting areas in healthcare

]]> http://healthcarefirms.com/Myriad-Genetics-Inc/feed/ 0 http://healthcarefirms.com/Nymox-Pharmaceutical-Corporation/ http://healthcarefirms.com/Nymox-Pharmaceutical-Corporation/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Nymox Pharmaceutical Corporation is a biopharmaceutical company specializing in the research and development of therapeutics and diagnostics for the aging population. Nymox has an extensive pipeline of products under development, including therapeutics for enlarged prostate (benign prostatic hyperplasia or BPH), a common affliction of males over the age of 50, and for Alzheimer’s disease, the most common cause of dementia in the elderly. The company has global patent rights for the use of statins to treat or prevent Alzheimer

]]> http://healthcarefirms.com/Nymox-Pharmaceutical-Corporation/feed/ 0 http://healthcarefirms.com/OncoGenex-Pharmaceuticals-Inc/ http://healthcarefirms.com/OncoGenex-Pharmaceuticals-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin OncoGenex is a biopharmaceutical company committed to the development and commercialization of new cancer therapies that address treatment resistance in cancer patients. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical have entered a global collaboration and license agreement to develop and commercialize OncoGenex’s lead drug candidate, OGX-011. The companies expect to initiate two Phase 3 trials in castrate resistant prostate cancer in 2010, and a third Phase 3 trial in non-small cell lung cancer in early 2011; OGX-427 is in Phase 1 clinical development; SN2310 has completed a Phase 1 clinical trial; and CSP-9222 and OGX-225 are currently in pre-clinical development. OGX-011, OGX-427 and OGX-225 utilize second-generation antisense technology, licensed from Isis Pharmaceuticals (NASDAQ: ISIS), to target and inhibit production of specific proteins which OncoGenex believes are important in tumor progression and treatment resistance. Key intellectual property related to OGX-011, OGX-427 and OGX-225 were discovered by the University of British Columbia and the Vancouver Prostate Centre, and were exclusively licensed to OncoGenex.

]]> http://healthcarefirms.com/OncoGenex-Pharmaceuticals-Inc/feed/ 0 http://healthcarefirms.com/Orchid-Cellmark-Inc/ http://healthcarefirms.com/Orchid-Cellmark-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Orchid Cellmark is a leading international provider of DNA testing services primarily for forensic and family relationship applications. Orchid Cellmark is one of the largest providers of forensic DNA testing services and its DNA results are used by the criminal justice system to assist with the identification of perpetrators, the exclusion of suspects and the exoneration of wrongfully convicted individuals. The company provides DNA family relationship testing to numerous child services organizations and individuals seeking to verify parentage. Orchid Cellmark also serves immigration and security authorities for DNA testing of individuals. In the agriculture field, the company provides DNA testing services for selective trait breeding. Orchid Cellmark’s strong market positions in these areas reflect the company’s accredited laboratories in the U.S. and U.K., its innovative genetic analysis technologies and expertise, and the company’s reputation for exceptional quality, reliability and customer service for nearly two decades.

]]> http://healthcarefirms.com/Orchid-Cellmark-Inc/feed/ 0 http://healthcarefirms.com/Palatin-Technologies-Inc/ http://healthcarefirms.com/Palatin-Technologies-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems. Palatin has a diverse pipeline of active development programs targeting melanocortin and natriuretic receptors, including products for treatment of sexual dysfunction, congestive heart failure, obesity and metabolic syndrome.

]]> http://healthcarefirms.com/Palatin-Technologies-Inc/feed/ 0 http://healthcarefirms.com/Pressure-BioSciences-Inc/ http://healthcarefirms.com/Pressure-BioSciences-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Pressure BioSciences, Inc. (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including genomic and proteomic sample preparation, pathogen inactivation, the control of chemical (primarily enzymatic) reactions, immunodiagnostics, and protein purification. PBI currently focuses its efforts on the development and sale of PCT-enhanced enzymatic digestion products designed specifically for the mass spectrometry marketplace, as well as sample preparation products for biomarker discovery, soil and plant biology, forensics, histology, and counter-bioterror applications.

]]> http://healthcarefirms.com/Pressure-BioSciences-Inc/feed/ 0 http://healthcarefirms.com/Quidel-Corp/ http://healthcarefirms.com/Quidel-Corp/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Quidel Corporation serves to enhance the health and well being of people around the globe through the development of rapid diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to healthcare providers. Marketed under the leading brand names QuickVue(R), D3 Direct Detection(TM) and Thyretain(TM), Quidel’s products aid in the detection and diagnosis of many critical diseases and conditions, including influenza, respiratory syncytial virus, Strep A, herpes, pregnancy, thyroid disease and fecal occult blood. Quidel’s research and development engine, including its Specialty Products Group, is also developing a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests to further improve the quality of healthcare in physicians’ offices and hospital and reference laboratories.

]]> http://healthcarefirms.com/Quidel-Corp/feed/ 0 http://healthcarefirms.com/Response-Genetics-Inc/ http://healthcarefirms.com/Response-Genetics-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Response Genetics Inc. (RGI) is focused on the development and sale of molecular diagnostic tests for cancer. RGI’s technologies enable extraction and analysis of genetic information from genes derived from tumor samples stored as formalin-fixed and paraffin-embedded specimens. In addition to diagnostic testing services, the Company generates revenue from the sales of its proprietary analytical pharmacogenomic testing services of clinical trial specimens to the pharmaceutical industry. RGI was founded in 1999 and its principal headquarters are located in Los Angeles, California.

]]> http://healthcarefirms.com/Response-Genetics-Inc/feed/ 0 http://healthcarefirms.com/Rosetta-Genomics-Ltd/ http://healthcarefirms.com/Rosetta-Genomics-Ltd/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000 the company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools. The company’s first three microRNA-based tests, miRview(TM) squamous, miRview(TM) mets and miRview(TM) meso, are commercially available through its Philadelphia-based CLIA-certified lab.

]]> http://healthcarefirms.com/Rosetta-Genomics-Ltd/feed/ 0 http://healthcarefirms.com/Sanguine-Corp/ http://healthcarefirms.com/Sanguine-Corp/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Sanguine Corporation is a public company primarily focused is the development of PHER-O2, a perfluorocarbon (PFC) emulsion with oxygen carrying properties that has immediate applications as an intravenous supplement to red blood cell function. The broad-based medical applications of PHER-O2 have strong market potential. Sanguine is a well-established organization with experts in the field of synthetic blood chemistry and development. Dr. Thomas C. Drees was a leader in the creation of Fluosol

]]> http://healthcarefirms.com/Sanguine-Corp/feed/ 0 http://healthcarefirms.com/SCOLR-Pharma-Inc/ http://healthcarefirms.com/SCOLR-Pharma-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin SCOLR Pharma, Inc. is a specialty pharmaceutical company. SCOLR Pharma

]]> http://healthcarefirms.com/SCOLR-Pharma-Inc/feed/ 0 http://healthcarefirms.com/SurModics-Inc/ http://healthcarefirms.com/SurModics-Inc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin SurModics’ vision is to extend and improve the lives of patients through technology innovation. The Company partners with the world’s foremost medical device, pharmaceutical and life science companies to develop and commercialize innovative products that result in improved diagnosis and treatment for patients. Core offerings include: drug delivery technologies (coatings, microparticles, nanoparticles, and implants); surface modification coating technologies that impart lubricity, prohealing, and biocompatibility capabilities; and components for in vitro diagnostic test kits and specialized surfaces for cell culture and microarrays. SurModics is headquartered in Eden Prairie, Minnesota and its SurModics Pharmaceuticals subsidiary is located in Birmingham, Alabama

]]> http://healthcarefirms.com/SurModics-Inc/feed/ 0 http://healthcarefirms.com/Synta-Pharmaceuticals-Corp/ http://healthcarefirms.com/Synta-Pharmaceuticals-Corp/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and disc

]]> http://healthcarefirms.com/Synta-Pharmaceuticals-Corp/feed/ 0 http://healthcarefirms.com/Trinity-Biotech-plc/ http://healthcarefirms.com/Trinity-Biotech-plc/#comments Sat, 20 Feb 2010 18:16:31 +0000 admin Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and blood coagulation disorders, and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide.

]]> http://healthcarefirms.com/Trinity-Biotech-plc/feed/ 0 http://healthcarefirms.com/illumina-inc/ http://healthcarefirms.com/illumina-inc/#comments Wed, 17 Feb 2010 12:38:22 +0000 admin Illumina is a leading developer, manufacturer, and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Using our proprietary technologies, we provide a comprehensive line of products and services that currently serve the sequencing, genotyping, and gene expression markets, and we expect to enter the market for molecular diagnostics. Our customers include leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Our tools provide researchers around the world with the performance, throughput, cost effectiveness, and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery and clinical research, allow diseases to be detected earlier, and permit better choices of drugs for individual patients.

]]> http://healthcarefirms.com/illumina-inc/feed/ 0 http://healthcarefirms.com/health-discovery-corp/ http://healthcarefirms.com/health-discovery-corp/#comments Wed, 17 Feb 2010 09:33:00 +0000 admin Health Discovery Corporation is a molecular diagnostics company that uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable.  It operates primarily in the emerging field of personalized medicine where such tools are critical to scientific discovery.  Its primary business consists of licensing its intellectual property and developing its own product line of biomarker-based diagnostic tests that include human genes and genetic variations, as well as gene, protein, and metabolic expression differences and image analysis in digital pathology and radiology.

]]> http://healthcarefirms.com/health-discovery-corp/feed/ 0 http://healthcarefirms.com/genetic-technologies-ltd/ http://healthcarefirms.com/genetic-technologies-ltd/#comments Sun, 14 Feb 2010 12:59:34 +0000 admin Genetic Technologies was an early pioneer in recognising important new applications for

]]> http://healthcarefirms.com/genetic-technologies-ltd/feed/ 0 http://healthcarefirms.com/exact-sciences-corporation/ http://healthcarefirms.com/exact-sciences-corporation/#comments Sun, 14 Feb 2010 12:59:34 +0000 admin Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.

]]> http://healthcarefirms.com/exact-sciences-corporation/feed/ 0 http://healthcarefirms.com/compugen-ltd/ http://healthcarefirms.com/compugen-ltd/#comments Sun, 14 Feb 2010 12:50:41 +0000 admin Compugen’s mission is to be the world leader in the discovery and licensing of product candidates to the drug and diagnostic industries under milestone and revenue sharing agreements. The Company’s increasing inventory of powerful and proprietary discovery platforms is enabling the predictive discovery – field after field – of numerous therapeutic and diagnostic product candidates. These discovery platforms are based on the Company’s decade-long focus on the predictive understanding of important biological phenomena at the molecular level. Compugen’s current collaborations include Biosite, Medarex, Inc., Merck & Co., Inc., Ortho-Clinical Diagnostics (a Johnson & Johnson company), Roche, Siemens Healthcare Diagnostics, Inc., and Teva Pharmaceutical Industries. In 2002, Compugen established an affiliate – Evogene Ltd. (TASE: EVGN.TA) – to utilize the Company’s in silico predictive discovery capabilities in the agricultural biotechnology field.

]]> http://healthcarefirms.com/compugen-ltd/feed/ 0 http://healthcarefirms.com/aspenbio-pharma-inc/ http://healthcarefirms.com/aspenbio-pharma-inc/#comments Sat, 13 Feb 2010 00:21:09 +0000 admin http://healthcarefirms.com/?p=148 AspenBio Pharma, Inc. is an emerging biotechnology company engaged in the discovery, research, development, manufacture, and licensing or marketing of novel diagnostics and drugs for human and animal healthcare. We have a growing product pipeline including a novel human diagnostic blood test for appendicitis and  recombinant reproduction hormones in development for animals of economic importance. The company is heavily focused on the development, testing and regulatory clearance of our first-generation blood-based human diagnostic test designed to rapidly aid in the diagnosis of  appendicitis in patients complaining of abdominal pain.

]]> http://healthcarefirms.com/aspenbio-pharma-inc/feed/ 0 http://healthcarefirms.com/amag-pharmaceuticals-inc/ http://healthcarefirms.com/amag-pharmaceuticals-inc/#comments Sat, 13 Feb 2010 00:01:33 +0000 admin http://healthcarefirms.com/?p=145 AMAG Pharmaceuticals is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of atherapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. The Company has three commercial products.

]]> http://healthcarefirms.com/amag-pharmaceuticals-inc/feed/ 0 http://healthcarefirms.com/abaxis-inc/ http://healthcarefirms.com/abaxis-inc/#comments Fri, 12 Feb 2010 23:40:40 +0000 admin http://healthcarefirms.com/?p=138 Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

]]> http://healthcarefirms.com/abaxis-inc/feed/ 0